NCT07764094Recruiting
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
Impact of Drug-Coated Balloon Procedural Factors on Angiographic and Clinical Outcomes of Percutaneous Coronary Intervention for De Novo Lesions: A Multicenter, Prospective, Observational Registry
Source: ClinicalTrials.gov · Last updated 28 Aug 2026
Brief summary (registry, in English)
This registry aimed to investigate drug-coated balloon procedural factors (particularly delivery time and inflation duration) to evaluate the impact on angiographic and clinical outcomes in patients undergoing percutaneous coronary intervention for de novo coronary lesions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 9 Aug 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT07764094
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Sept 2026 to the primary completion date, 31 Dec 2027
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent participation in another clinical trial
Other illness
- Acute myocardial infarction within 72 hours
- Severe heart failure (NYHA class IV)
- Severe hepatic or renal insufficiency
- Allergy to drug-coated balloon components or antiplatelet agents, or intolerance to dual antiplatelet therapy
Other
- Life expectancy \<12 months
- Pregnancy or breastfeeding
- In-stent restenosis
- Unsuccessful recanalization of main vessel or side branch chronic total occlusion
- Hemodynamic instability
Who the study is looking for
- Age ≥18 years
- Stable coronary artery disease or unstable angina
- De novo coronary lesion (reference vessel diameter 2.25-4.0 mm; lesion length ≤40 mm)
- Planned DCB strategy for PCI
- Written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chuzhou First People's Hospital Coordinator of this site? Confirm its status | Chuzhou | China | Recruiting |
| Huai'an Second People's Hospital Coordinator of this site? Confirm its status | Huai'an | China | Recruiting |
| Lianyungang First People's Hospital Coordinator of this site? Confirm its status | Lianyungang | China | Recruiting |
| Nanjing First Hospital Coordinator of this site? Confirm its status | Nanjing | China | Recruiting |
| Tongling People's Hospital Coordinator of this site? Confirm its status | Tongling | China | Recruiting |
| Xuzhou Second People's Hospital Coordinator of this site? Confirm its status | Xuzhou | China | Recruiting |
| Yixing People's Hospital Coordinator of this site? Confirm its status | Yixing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.